BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24238267)

  • 1. Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12 months of follow-up.
    Howard DL; Wayman R; Strickland JL
    J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):358-65. PubMed ID: 24238267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
    East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M; Liblanc M
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z; Biro FM; Kollar LM
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL; Story M
    J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with contraceptive satisfaction in adolescent women using the IUD.
    Friedman JO
    J Pediatr Adolesc Gynecol; 2015 Feb; 28(1):38-42. PubMed ID: 25555299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms and Depo-Provera.
    Westhoff C; Truman C; Kalmuss D; Cushman L; Davidson A; Rulin M; Heartwell S
    Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depo-Provera: costs eat up clinic contraceptive budgets.
    Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
    Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T
    Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introducing more contraceptive methods in Jordan.
    Gallagher M
    AVSC News; 1998; 36(1):3, 8. PubMed ID: 12321883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depo-provera: clinical evaluation.
    Mukherjea M
    Contracept Deliv Syst; 1981 Jul; 2(3):259-69. PubMed ID: 12278913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents.
    Harel Z; Biro F; Kollar L; Riggs S; Flanagan P; Vaz R
    J Pediatr Adolesc Gynecol; 2002 Jun; 15(3):153-8. PubMed ID: 12106752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting contraceptive options.
    Kaunitz AM
    Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):321-332. PubMed ID: 30466840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
    Usinger KM; Gola SB; Weis M; Smaldone A
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.